Home » Schering’s Potential Anti-Clotting Blockbuster
Schering’s Potential Anti-Clotting Blockbuster
Recently announced safety problems with Lilly's prasugrel could mean good news for Schering and its experimental anti-clotting drug TRA, but it would be a year before it could enter the market.
StockHouse.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May